Albany Molecular Research (AMRI) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts AMRI Hot Sheet
Price: $21.74 --0%
Financial Fact:
Total operating expenses: 168.4M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Total operating expenses: 168.4M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Albany Molecular Research (NASDAQ: AMRI) reported Q1 EPS of $0.02, $0.03 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $53.7 million versus the consensus estimate of $52.12 million.
For earnings history and earnings-related data on Albany Molecular Research (AMRI) click here.
For earnings history and earnings-related data on Albany Molecular Research (AMRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
- Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
